Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2025-04-28 Delisting Announcement
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于公司股票被实施退市风险警示及其他风险警示暨停牌的公告
Delisting Announcement Classification · 100% confidence The document is an official announcement from the company regarding the implementation of delisting risk warnings and other risk warnings on its stock, including details about stock suspension, stock name change, reasons for the risk warnings, and potential delisting risks. It does not contain financial statements or detailed financial reports but rather regulatory information about stock trading status and risk warnings. The document length is 3153 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of a Delisting Announcement (DLST).
2025-04-28 Chinese
简式权益变动报告书（康怡投资）
Major Shareholding Notification Classification · 100% confidence The document is a detailed report about a significant change in shareholding involving Shanghai Kangyi Investment Co., Ltd. and related parties transferring a large block of shares in Lvkang Biochemical Co., Ltd. It includes detailed information about the parties involved, the share transfer agreement, the number of shares before and after the transfer, the price, payment schedule, legal and regulatory compliance, and approvals required. The document references Chinese securities laws and regulations, Shenzhen Stock Exchange rules, and includes statements about the disclosure obligations and risk warnings. The content is focused on the disclosure of a change in significant share ownership and the related agreement, not on financial results, earnings, or management commentary. It is not an annual report, earnings release, or management report. It is not a proxy statement or voting results announcement. It is not a merger or acquisition filing, but a shareholding change notification. The document is comprehensive and exceeds 5,000 characters, so it is not a mere announcement of a report. Therefore, the document fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2025-04-28 Chinese
简式权益变动报告书（长鑫贰号）
Major Shareholding Notification Classification · 100% confidence The document is a detailed report about a change in shareholding by an information disclosure obligor (上饶市长鑫贰号企业管理中心（有限合伙）) in the listed company 绿康生化股份有限公司. It includes specifics about the share transfer agreement, share quantities before and after the transaction, the purpose of the shareholding change, approval procedures, and legal declarations. The document references relevant Chinese securities laws and regulations, and it is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." This type of document corresponds to notifications about changes in major shareholdings or equity interests. It is not an annual report, earnings release, or management report, nor is it a proxy statement or voting result announcement. It is a formal disclosure of a significant shareholding change, consistent with the category "Major Shareholding Notification (MRQ)." The document length is substantial (15,000 characters), and it contains detailed substantive information, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2025-04-28 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report' for the fiscal year 2024. It contains an auditor's opinion on the effectiveness of the company's internal control over financial reporting as of December 31, 2024. The content includes responsibilities of the company and auditors, inherent limitations of internal control, and the auditor's conclusion on the internal control effectiveness. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document is not a full annual report (10-K) but a specific audit report on internal controls. The length and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-28 Chinese
关于公司2024年度拟不进行利润分配的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding its 2024 annual profit distribution plan, specifically stating that no profit distribution (dividends) will be made for the year 2024. It includes details about the audited net profit, references to board and supervisory meetings, and compliance with relevant regulations. The document is relatively short (1509 characters) and primarily serves as a formal announcement of the company's dividend decision rather than a full financial report. It also references an audit report but does not contain detailed financial statements or comprehensive financial analysis itself. Therefore, it fits best as a Notice of Dividend Amount (DIV) announcement, as it communicates dividend policy and payment decisions to shareholders.
2025-04-28 Chinese
第五届董事会独立董事专门会议第八次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors' special meeting of the company's board, discussing approval of a related party transaction involving interest payments. It is a board/management level decision document, not a full report or announcement of financial results. The content focuses on governance and board approval matters, fitting the Board/Management Information category.
2025-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.